0001562180-24-005595.txt : 20240703 0001562180-24-005595.hdr.sgml : 20240703 20240703161433 ACCESSION NUMBER: 0001562180-24-005595 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240701 FILED AS OF DATE: 20240703 DATE AS OF CHANGE: 20240703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Eatwell Victoria CENTRAL INDEX KEY: 0002009135 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40791 FILM NUMBER: 241100278 MAIL ADDRESS: STREET 1: C/O 2SEVENTY BIO, INC. STREET 2: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 2seventy bio, Inc. CENTRAL INDEX KEY: 0001860782 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 863658454 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02210 BUSINESS PHONE: 339-499-9300 MAIL ADDRESS: STREET 1: 60 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02210 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-07-01 false 0001860782 2seventy bio, Inc. TSVT 0002009135 Eatwell Victoria 60 BINNEY STREET CAMBRIDGE MA 02142 false true false false Chief Financial Officer false Common Stock 2024-07-01 4 A false 245864.00 0.00 A 341344.00 D Common Stock 2024-07-02 4 S false 12.00 4.0178 D 341332.00 D This restricted stock unit award vests ratably over a two-year period in annual installments with the first installment vesting on July 1, 2025, subject to the Reporting Person's continued service through the applicable vesting date. Shares were sold to cover tax withholding obligations incurred in connection with the vesting of restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.02, inclusive. The Reporting Person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Iya Kessler, Attorney-in-Fact 2024-07-03